摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

α,α'-dibromoglutaric acid methyl, t-butyl ester | 121049-93-2

中文名称
——
中文别名
——
英文名称
α,α'-dibromoglutaric acid methyl, t-butyl ester
英文别名
t-butyl methyl 2,4-dibromoglutarate;5-O-tert-butyl 1-O-methyl 2,4-dibromopentanedioate
α,α'-dibromoglutaric acid methyl, t-butyl ester化学式
CAS
121049-93-2
化学式
C10H16Br2O4
mdl
——
分子量
360.043
InChiKey
JGBOVZDMWYUZPH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    331.6±42.0 °C(Predicted)
  • 密度:
    1.580±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    16
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    52.6
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Azetidine derivatives, compositions and methods of treating
    申请人:Fidia-Georgetown Institute for the Neurosciences
    公开号:US04946839A1
    公开(公告)日:1990-08-07
    This invention relates to novel azetidines and derivative thereof, as well as to pharmaceutical compositions and methods of treating memory and learning disorders. Another aspect of the invention relates to a method of utilizing the compounds and compositions as biological tools and materials for characterizing excitatory amino acid receptor systems. A further aspect of the invention relates to a method of treating PCP toxicity and abuse.
    本发明涉及新型氮杂四元环及其衍生物,以及制备治疗记忆和学习障碍的药物组合物和方法。本发明的另一个方面涉及利用化合物和组合物作为生物工具和材料来表征兴奋性氨基酸受体系统的方法。本发明的另一个方面涉及一种治疗PCP毒性和滥用的方法。
  • Azetidine derivatives to treat memory and learning disorders
    申请人:FIDIA-Georgetown Institute for the Neurosciences
    公开号:US04990504A1
    公开(公告)日:1991-02-05
    This invention relates to novel azetidines and derivatives thereof, as well as to pharmaceutical compositions and methods of treating memory and learning disorders. Another aspect of the invention relates to a method of utilizing the compounds and compositions as biological tools and materials for characterizing excitatory amino acid receptor systems. A further aspect of the invention relates to a method of treating PCP toxicity and abuse.
    本发明涉及新型的氮杂四元环及其衍生物,以及制备药物组合物和治疗记忆和学习障碍的方法。本发明的另一个方面涉及将这些化合物和组合物作为生物学工具和材料用于表征兴奋性氨基酸受体系统的方法。本发明的进一步方面涉及一种治疗PCP中毒和滥用的方法。
  • Azetidine derivatives, compositions and their use
    申请人:FIDIA-GEORGETOWN INSTITUTE FOR THE NEUROSCIENCES
    公开号:EP0299513A1
    公开(公告)日:1989-01-18
    This invention relates to novel azetidines and derivatives thereof, as well as to pharmaceutical compositions and their use for treating memory and learning disorders. Another aspect of the invention relates to a method of utilizing the compounds and compositions as biological tools and materials for characterizing excitatory amino acid receptor systems. A further aspect of the invention relates to a method of treating PCP toxicity and abuse.
    本发明涉及新型氮杂环丁烷及其衍生物,以及药物组合物及其用于治疗记忆和学习障碍的用途。本发明的另一方面涉及一种利用这些化合物和组合物作为生物工具和材料来表征兴奋性氨基酸受体系统的方法。本发明的另一方面涉及一种治疗五氯苯酚毒性和滥用的方法。
  • Synthesis and bioactivity of a new class of rigid glutamate analogs. Modulators of the N-methyl-D-aspartate receptor
    作者:Alan P. Kozikowski、Werner Tuckmantel、Ian J. Reynolds、Jarda T. Wroblewski
    DOI:10.1021/jm00168a007
    日期:1990.6
    A variety of derivatives of azetidine-2,4-dicarboxylic acid were synthesized and examined for their ability to stimulate 45Ca2+ uptake in cultures of cerebellar granule cells. Of the compounds tested, the cis-azetidine-2,4-dicarboxylic acid (10f) was found to be the most potent agent in potentiating glutamate, aspartate, or N-methyl-D-aspartate (NMDA) stimulated 45Ca2+ uptake at the NMDA receptor. The mechanism of action of 10f was further investigated in [3H]MK-801 binding assays and [3H]GABA release from cultured embryonic rat forebrain neurons. All of the results from the functional studies of azetidine 10f are consistent with a selectivity of action at the NMDA receptor. Moreover, azetidine 10f appears to exhibit a dual type of action, behaving as a glutamate-like agonist at higher concentrations and as a positive modulator at concentrations below 50 microM.
  • US4946839A
    申请人:——
    公开号:US4946839A
    公开(公告)日:1990-08-07
查看更多